x

RSS Newsfeeds

See all RSS Newsfeeds

Global Regions

United States ( XML Feed )

Jul 13, 2016 11:46 EST

SANABIT Technologies: Our medical devices uses safe levels of magnetic fields to stimulate the efficiency of the mitochondria for accelerating tissue closure and bone healing.

iCrowdNewswire - Jul 13, 2016

Sanabit logo

 

SANABIT Technologies

Our medical devices uses safe levels of magnetic fields to stimulate the efficiency of the mitochondria for accelerating tissue closure and bone healing.

 

Picture6

Company Summary

 

Benefits of magnetic fields on the enhancement of mitochondrial efficiency were identified by Dr. Arthur Moss and others during ongoing clinical research. Our Minimum Viable Product (MVP) application of this effect is achieved through the integration and packaging of precision magnetic components into form factors suitable for accelerated tissue closure and/or bone healing devices. Our MVP can be expanded to PVD, Cardiology, Alzheimer’s.

 

Team

  • F9153de2 d792 45cb 9fe7 f4675466a97b
    Professor of Medicine, URMC

    Dr. Moss is a Professor of Medicine (Cardiology) and Founding Director of the Heart Research Follow-up Program at the University of Rochester School of Medicine and Dentistry in Rochester, New York. major areas of interest are in genetic and acquired heart rhythm disorders (arrhythmias), acute and chronic coronary heart disease, prevention of sudden cardiac death, clinical trials involving drugs and devices (ICD and CRT).

     

  • Default avatar
    Dr. Joseph Marasco
    COO
    Unconfirmed

    Former CEO for Diffinity Genomics (developing novel tools for DNA purification) as well as Chiral Quest Corp. Before that as well as BD for Dow Comical and others. 35 years of technical and business leadership in the Biomedical devices community. Was CEO/President of four life-science firms, three of which he co-founded.

  •  
    343dabb2 f3b8 4b13 b064 6adf9bfebffe
    Professor of Medicine, Thomas Jefferson University

    Research objective is to elucidate an integrative mechanism by which mitochondria control intracellular Ca2+ homeostasis, energy metabolism, and reactive oxygen species (ROS) generation under both physiological and pathological conditions. Current research effort is to focus on the crosstalk Ca2+ signaling between mitochondria and sarcoplasmic reticulum during excitation-contraction coupling in normal and failing hearts.

     

  • Default avatar
    J. Montieth Estes
    Chief Investment Counsel
    Unconfirmed

    J. Montieth “Monty” Estes concentrates his practice on advising emerging technology companies, including high tech start-ups, on legal and business issues, including how to develop and protect their intellectual property assets and how to secure stages of funding.

Contact Information:

Joseph Fargnoli

View Related News >
support